Teva, Already Up 26% This Year, Surges Again On First-Of-Its-Kind Approval ...Middle East

News by : (IBD) -

Teva stock surged Friday after the FDA approved its schizophrenia drug, a once-monthly injectable treatment for the disease.

Teva, Already Up 26% This Year, Surges Again On First-Of-Its-Kind Approval Investor's Business Daily.

Hence then, the article about teva already up 26 this year surges again on first of its kind approval was published today ( ) and is available on IBD ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Teva, Already Up 26% This Year, Surges Again On First-Of-Its-Kind Approval )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار